510(k) K252280

Elecsys Anti-SARS-CoV-2 S by Roche Diagnostics — Product Code QVP

K252280 is an FDA 510(k) premarket notification submitted by Roche Diagnostics for the device "Elecsys Anti-SARS-CoV-2 S". The FDA issued a decision of Substantially Equivalent on Apr 13, 2026. The device falls under product code QVP (Sars-Cov-2 Serology Test), a Class II device regulated under 21 CFR 866.3983. Roche Diagnostics has 456 other 510(k) clearances on record.

Clearance details

Decision
SESE (Substantially Equivalent)
Decision Date
Apr 13, 2026
Date Received
Jul 22, 2025
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device classification

Device Name
Sars-Cov-2 Serology Test
Device Class
Class II
Regulation Number
866.3983
Review Panel
MI
Submission Type
510(k)

A SARS-CoV-2 serology test is a prescription in vitro diagnostic device for the detection of specific binding antibodies to SARS-CoV-2 in clinical specimens. The detection of SARS-CoV-2 antibodies is intended to aid in identifying individuals with an adaptive immune response to SARS-CoV-2. The test is not intended for the diagnosis of acute SARS-CoV-2 infection, nor screening blood, plasma, cells, or tissue donors.

Need the full FDA record for Roche Diagnostics? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: FDA 510(k) database entry for K252280. Report a data issue: hello@regdatalab.com.